Peptilogics doses first subject in periprosthetic joint infection trial
Musculoskeletal Disorders
Pipeline Moves: trial completions in glaucoma, lung, and oncology indications
The Clinical Trials Arena team also reviews a termination in severe swelling and topline results in cervical dystonia trials
FDA places partial hold on Avidity’s Phase I/II myotonic dystrophy trial
Atamyo doses first subject in Phase I/II muscular dystrophy therapy trial
Santhera and ReveraGen dose first subject in Phase II trial of BMD drug
Pipeline Moves: Lilly completes Phase II rheumatoid arthritis trial, next phase prospects rise
Saol enrols first subject in Phase II osteoarthritis trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
